• Je něco špatně v tomto záznamu ?

Curation of gene-disease relationships in primary antibody deficiencies using the ClinGen validation framework

A. Nieto-Patlán, J. Ross, S. Mohan, MK. Paczosa, R. Soliman, O. Sarmento, E. Aliu, L. Thiyagarajan, A. Chandra, C. Picard, K. Warnatz, S. Jolles, H. Lesmana, PJ. Maglione, CD. Platt, A. Sediva, KE. Sullivan, K. Zhang, F. Raval, SG. Tangye, RS. Abraham

. 2025 ; 155 (5) : 1647-1663. [pub] 20250116

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc25015969

BACKGROUND: The Clinical Genome Resource (ClinGen) is an international collaborative effort among scientists and clinicians, diagnostic and research laboratories, and the patient community. Using a standardized framework, ClinGen has established guidelines to classify gene-disease relationships as definitive, strong, moderate, and limited on the basis of available scientific and clinical evidence. When the genetic and functional evidence for a gene-disease relationship has conflicting interpretations or contradictory evidence, they can be disputed or refuted. OBJECTIVE: We assessed genes related to primary antibody deficiencies. METHODS: The ClinGen Antibody Deficiencies Gene Curation Expert Panel, using the ClinGen framework, classified genes related to primary antibody deficiency that primarily affect B-cell development and/or function, and that account for the largest proportion of inborn errors of immunity or primary immunodeficiencies. RESULTS: The expert panel curated a total of 65 genes associated with humoral immune defects to validate 74 gene-disease relationships. Of these, 40 were classified as definitive, 1 as strong, 16 as moderate, 15 as limited, and 2 as disputed. The curation process involved reviewing 490 patient records and 3546 associated human phenotype ontology entries. The 3 most frequently observed terms related to primary antibody deficiency were decreased circulating antibody level, pneumonia, and lymphadenopathy. CONCLUSIONS: These curations (publicly available at ClinicalGenome.org) represent the first effort to provide a comprehensive genetic and phenotypic revision of genetic disorders affecting humoral immunity, as reviewed and approved by experts in the field.

Boston Children's Hospital Boston Mass

Center for Chronic Immunodeficiency Medical Center University of Freiburg Faculty of Medicine University of Freiburg Freiburg Germany

Departamento de Genética Hospital Infantil de México Federico Gómez Mexico City Mexico

Department of Allergy Immunology and Rheumatology Center for Human Immunobiology Texas Children's Hospital Houston Tex

Department of Clinical Immunology Cambridge University Hospitals NHS Foundation Trust Cambridge United Kingdom

Department of Genetics University of North Carolina School of Medicine Chapel Hill NC

Department of Immunology University Hospital Zurich Zurich Switzerland

Department of Medical Genetics and Genomics Cleveland Clinic Lerner College of Medicine Case Western Reserve University Cleveland Ohio

Department of Medicine Boston University Chobanian and Avedisian School of Medicine Boston Mass

Department of Medicine University of Cambridge Cambridge United Kingdom

Department of Pediatric Hematology Oncology and BMT Cleveland Clinic Lerner College of Medicine Case Western Reserve University Cleveland Ohio

Department of Pediatrics Baylor College of Medicine Houston Tex

Department of Rheumatology and Clinical Immunology Medical Center University of Freiburg Faculty of Medicine University of Freiburg Freiburg Germany

Garvan Institute of Medical Research Darlinghurst Australia

GoBroad Healthcare Group GoBroad Clinical Research Center Boren Hospital Beijing China

Immunodeficiency Centre for Wales University Hospital of Wales Cardiff United Kingdom

Invitae Corporation San Francisco Calif

Laboratory of Lymphocyte Activation and Susceptibility to EBV infection Inserm UMR 1163 Institut Imagine Paris France

Milton S Hershey Medical Center Hershey Pa

Motol University Hospital and the 2nd Faculty of Medicine Charles University Prague Czech Republic

Nationwide Children's Hospital Columbus Ohio

Queen Mary University of London London United Kingdom

Quest Diagnostics Secaucus NJ

School of Clinical Medicine Faculty of Medicine and Health UNSW Sydney Sydney Australia

School of Clinical Medicine University of New South Wales Sydney Australia

Study Center for Primary Immunodeficiencies Necker Enfants Malades Hospital Assistance Publique Hôpitaux de Paris Paris France

Sydney Children's Hospitals Network Sydney Australia

The Children's Hospital of Philadelphia Philadelphia Pa

Université Paris Cité Paris France

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25015969
003      
CZ-PrNML
005      
20250731091411.0
007      
ta
008      
250708s2025 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.jaci.2025.01.005 $2 doi
035    __
$a (PubMed)39826876
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Nieto-Patlán, Alejandro $u Department of Pediatrics, Baylor College of Medicine, Houston, Tex; Department of Allergy, Immunology and Rheumatology, Center for Human Immunobiology, Texas Children's Hospital, Houston, Tex; Departamento de Genética, Hospital Infantil de México Federico Gómez, Mexico City, Mexico
245    10
$a Curation of gene-disease relationships in primary antibody deficiencies using the ClinGen validation framework / $c A. Nieto-Patlán, J. Ross, S. Mohan, MK. Paczosa, R. Soliman, O. Sarmento, E. Aliu, L. Thiyagarajan, A. Chandra, C. Picard, K. Warnatz, S. Jolles, H. Lesmana, PJ. Maglione, CD. Platt, A. Sediva, KE. Sullivan, K. Zhang, F. Raval, SG. Tangye, RS. Abraham
520    9_
$a BACKGROUND: The Clinical Genome Resource (ClinGen) is an international collaborative effort among scientists and clinicians, diagnostic and research laboratories, and the patient community. Using a standardized framework, ClinGen has established guidelines to classify gene-disease relationships as definitive, strong, moderate, and limited on the basis of available scientific and clinical evidence. When the genetic and functional evidence for a gene-disease relationship has conflicting interpretations or contradictory evidence, they can be disputed or refuted. OBJECTIVE: We assessed genes related to primary antibody deficiencies. METHODS: The ClinGen Antibody Deficiencies Gene Curation Expert Panel, using the ClinGen framework, classified genes related to primary antibody deficiency that primarily affect B-cell development and/or function, and that account for the largest proportion of inborn errors of immunity or primary immunodeficiencies. RESULTS: The expert panel curated a total of 65 genes associated with humoral immune defects to validate 74 gene-disease relationships. Of these, 40 were classified as definitive, 1 as strong, 16 as moderate, 15 as limited, and 2 as disputed. The curation process involved reviewing 490 patient records and 3546 associated human phenotype ontology entries. The 3 most frequently observed terms related to primary antibody deficiency were decreased circulating antibody level, pneumonia, and lymphadenopathy. CONCLUSIONS: These curations (publicly available at ClinicalGenome.org) represent the first effort to provide a comprehensive genetic and phenotypic revision of genetic disorders affecting humoral immunity, as reviewed and approved by experts in the field.
650    _2
$a lidé $7 D006801
650    _2
$a genetická predispozice k nemoci $7 D020022
650    12
$a primární imunodeficience $x genetika $7 D000081207
650    _2
$a databáze genetické $7 D030541
650    12
$a syndromy imunologické nedostatečnosti $x genetika $7 D007153
655    _2
$a časopisecké články $7 D016428
700    1_
$a Ross, Justyne $u Department of Genetics, University of North Carolina School of Medicine, Chapel Hill, NC
700    1_
$a Mohan, Shruthi $u Department of Genetics, University of North Carolina School of Medicine, Chapel Hill, NC
700    1_
$a Paczosa, Michelle K $u Quest Diagnostics, Secaucus, NJ
700    1_
$a Soliman, Rasha $u Queen Mary University of London, London, United Kingdom
700    1_
$a Sarmento, Olga $u Invitae Corporation, San Francisco, Calif
700    1_
$a Aliu, Ermal $u Milton S. Hershey Medical Center, Hershey, Pa
700    1_
$a Thiyagarajan, Lavvina $u Sydney Children's Hospitals Network, Sydney, Australia; School of Clinical Medicine, University of New South Wales, Sydney, Australia
700    1_
$a Chandra, Anita $u Department of Clinical Immunology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom; Department of Medicine, University of Cambridge, Cambridge, United Kingdom
700    1_
$a Picard, Capucine $u Université Paris Cité, Paris, France; Study Center for Primary Immunodeficiencies, Necker-Enfants Malades Hospital, Assistance Publique Hôpitaux de Paris (APHP), Paris, France; Laboratory of Lymphocyte Activation and Susceptibility to EBV infection, Inserm UMR 1163, Institut Imagine, Paris, France
700    1_
$a Warnatz, Klaus $u Department of Rheumatology and Clinical Immunology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; Center for Chronic Immunodeficiency, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; Department of Immunology, University Hospital Zurich, Zurich, Switzerland
700    1_
$a Jolles, Stephen $u Immunodeficiency Centre for Wales, University Hospital of Wales, Cardiff, United Kingdom
700    1_
$a Lesmana, Harry $u Department of Medical Genetics and Genomics, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, Ohio; Department of Pediatric Hematology, Oncology and BMT, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, Ohio
700    1_
$a Maglione, Paul J $u Department of Medicine, Boston University Chobanian, and Avedisian School of Medicine, Boston, Mass
700    1_
$a Platt, Craig D $u Boston Children's Hospital, Boston, Mass
700    1_
$a Sediva, Anna $u Motol University Hospital and the 2nd Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Sullivan, Kathleen E $u The Children's Hospital of Philadelphia, Philadelphia, Pa
700    1_
$a Zhang, Kejian $u GoBroad Healthcare Group, GoBroad Clinical Research Center, Boren Hospital, Beijing, China
700    1_
$a Raval, Forum $u Invitae Corporation, San Francisco, Calif
700    1_
$a Tangye, Stuart G $u Garvan Institute of Medical Research, Darlinghurst, Australia; School of Clinical Medicine, Faculty of Medicine and Health, UNSW Sydney, Sydney, Australia
700    1_
$a Abraham, Roshini S $u Nationwide Children's Hospital, Columbus, Ohio. Electronic address: Roshini.Abraham@nationwidechildrens.org
773    0_
$w MED00002505 $t Journal of allergy and clinical immunology $x 1097-6825 $g Roč. 155, č. 5 (2025), s. 1647-1663
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39826876 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250708 $b ABA008
991    __
$a 20250731091405 $b ABA008
999    __
$a ok $b bmc $g 2366667 $s 1253094
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 155 $c 5 $d 1647-1663 $e 20250116 $i 1097-6825 $m Journal of allergy and clinical immunology $n J Allergy Clin Immunol $x MED00002505
LZP    __
$a Pubmed-20250708

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...